Recently, various biomarkers of DN have been identified, including kidney injury molecule-1 (KIM-1), cystatin C, neutrophil gelatinase-associated lipocalin (NGAL), and inflammatory markers. This evidence concerns the gene LCN2 and liver dysplastic nodule.